Nicholas Hoffman & Company’s Amyris Inc. AMRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-100,000
Closed -$103K 285
2023
Q2
$103K Hold
100,000
﹤0.01% 271
2023
Q1
$136K Hold
100,000
0.01% 263
2022
Q4
$153K Hold
100,000
0.02% 255
2022
Q3
$292K Hold
100,000
0.01% 203
2022
Q2
$185K Hold
100,000
0.01% 251
2022
Q1
$436K Buy
100,000
+20,000
+25% +$89.7K 0.02% 185
2021
Q4
$433K Hold
80,000
0.01% 184
2021
Q3
$1.1M Hold
80,000
0.19% 97
2021
Q2
$1.31M Hold
80,000
0.24% 82
2021
Q1
$1.53M Hold
80,000
0.31% 59
2020
Q4
$494K Hold
80,000
0.11% 137
2020
Q3
$234K Hold
80,000
0.06% 178
2020
Q2
$342K Hold
80,000
0.1% 143
2020
Q1
$205K Hold
80,000
0.07% 170
2019
Q4
$247K Hold
80,000
0.07% 173
2019
Q3
$381K Hold
80,000
0.12% 138
2019
Q2
$285K Hold
80,000
0.09% 148
2019
Q1
$167K Buy
+80,000
New +$316K 0.05% 182

Other funds holding AMRS

Nicholas Hoffman & Company's AMRS Position: Q3 2023 in Review

Nicholas Hoffman & Company sold out of Amyris Inc. (AMRS) in Q3 2023, closing a stake of 100,000 shares — an estimated $103K sold.

Nicholas Hoffman & Company first reported a position in AMRS in Q1 2019 and held it in 18 quarters. The position peaked at $1.53M in Q1 2021. 18 funds tracked by Wall St. Rank hold AMRS as of Q3 2023.

  • Nicholas Hoffman & Company reported no remaining Amyris Inc. position as of Q3 2023 after selling out during the quarter.
  • Nicholas Hoffman & Company sold 100,000 Amyris Inc. shares in Q3 2023, an estimated $103K.
  • Nicholas Hoffman & Company first reported a position in Amyris Inc. in Q1 2019 and held it in 18 quarters.
  • Nicholas Hoffman & Company's Amyris Inc. position peaked at $1.53M in Q1 2021.
  • 18 funds tracked by Wall St. Rank held Amyris Inc. as of Q3 2023.

Based on Nicholas Hoffman & Company's 13F filing for Q3 2023, filed 6 Nov 2023.